🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: recombinant interferon gamma

Found 244 matching trials

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

PHASE2

Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condit...

Status

Terminated

Location

MD Anderson Cancer Center

Start Date

2020-06-02

Trial ID

NCT03985423

Treatments Being Tested

Emapalumab-Lzsg

Study of Gamma Interfereon in Metastatic Colorectal Carcinoma

PHASE2

The purpose of this study is to evalute the response and toxicity of metast...

Status

Completed

Location

The West Clinic

Start Date

2006-02

Trial ID

NCT00786643

Treatments Being Tested

5-Fluorouracil Leucovorin (LV)Gamma-Interferon-1b (IFN-γ)Bevacizumab

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

PHASE3

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Completed

Location

Herbert Irving Comprehensive Cancer Center

Start Date

1996-05

Trial ID

NCT00008203

Treatments Being Tested

aldesleukin recombinant interferon gamma carboplatin cyclophosphamide cyclosporine thiotepa autologous bone marrow transplantation peripheral blood stem cell transplantation

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

N/A

This is a prospective cohort study of persons tested for latent tuberculosi...

Status

Completed

Location

Maricopa County Department of Public Health

Start Date

2012-10

Trial ID

NCT01622140

A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant

N/A

Clinical study designed to collect blood for research purposes in patients ...

Status

Terminated

Location

Algemeen Ziekenhuis Delta - Campus Rumbeke

Start Date

2020-11-16

Trial ID

NCT04494061

Treatments Being Tested

blood collection

Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients

N/A

For diagnosis of active tuberculosis, interferon-γ release assay based myco...

Status

Completed

Location

Yonsei Univ.

Start Date

2009-07

Trial ID

NCT00962676

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

PHASE2

The goal of this clinical trial is to evaluate the efficacy of using SP-002...

Status

Recruiting

Location

Research Site

Start Date

2024-04-09

Trial ID

NCT06344052

Treatments Being Tested

SP-002 Vismodegib

Training Protocol on the Natural History of Tuberculosis

N/A

Background: \- Tuberculosis (TB) is an infectious disease that affects num...

Status

Recruiting

Location

National Institutes of Health Clinical Center

Start Date

2011-06-30

Trial ID

NCT01212003

Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis

PHASE3

The primary purposes of the study are to evaluate the effectiveness of Inga...

Status

Completed

Location

Multiple Locations

Start Date

2009-01-29

Trial ID

NCT05378646

Treatments Being Tested

Interferon gamma human recombinant (IFN-G)

COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)

N/A

The study is an evaluation of the diagnostic performance of different tests...

Status

Completed

Location

UH Montpellier

Start Date

2017-01-31

Trial ID

NCT06408129

Previous Next